Actively Recruiting
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
Led by University of California, San Francisco · Updated on 2025-06-08
260
Participants Needed
2
Research Sites
172 weeks
Total Duration
On this page
Sponsors
U
University of California, San Francisco
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).
CONDITIONS
Official Title
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- HIV positive
- At least 40 years of age
- English-speaking
You will not qualify if you...
- Existing clinical atherosclerotic cardiovascular disease (ASCVD)
- Pregnant
- Unwilling or unable to provide informed consent
- Does not own a smartphone
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Zuckerberg San Francisco General Hospital
San Francisco, California, United States, 94110
Actively Recruiting
2
University of California San Francisco
San Francisco, California, United States, 94115
Actively Recruiting
Research Team
M
Megan McLaughlin, MD, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here